|
0
|
|
Immune context and treatment timing associated with seizure freedom after rituximab in autoimmune limbic encephalitis.
(linkinghub.elsevier.com)
|
Dik A
…
Kovac S
iScience
2026-07-10
|
#encephalitis
#autoimmunity
#seizures
#immunotherapy
#csf
|
|
0
|
|
Antibody-drug conjugates and the need for third-modality regulatory science.
(linkinghub.elsevier.com)
|
Jiang N
…
Li N
Cell Med
2026-07-10
|
#immunotherapy
#regulation
#pharmacology
#manufacturing
#oncology
|
|
0
|
|
Prediction of microvascular invasion in hepatocellular carcinoma using contrast-enhanced ultrasound and deep learning.
(nature.com)
|
Pang C
…
Liang P
Nature Communications
2026-07-10
|
#deep learning
#hepatocellular carcinoma
#imaging
#prognosis
#immunotherapy
|
|
0
|
|
Kaempferol's potential in targeting IL-17-mediated inflammatory pathways for colorectal cancer treatment.
(academic.oup.com)
|
Ye L
…
Liu H
Journal of Immunology
2026-07-10
|
#colorectal cancer
#inflammation
#immunotherapy
#cytokine
#immunooncology
|
|
0
|
|
Epigenetic landscape, key transcriptional regulators, and in vivo identification of human Tr1 cells.
(science.org)
|
Cepika AM
…
Roncarolo MG
Science Advances
2026-07-10
|
#transcriptomics
#immunology
#epigenetics
#differentiation
#immunotherapy
|
|
0
|
|
Polyvinyl chloride promotes radioresistance in hepatocellular carcinoma by inhibiting radiotherapy-induced CD8(+) T cell differentiation.
(nature.com)
|
Zhang H
…
Sheng H
Nature Communications
2026-07-10
|
#hepatocellular carcinoma
#radiotherapy
#immunotherapy
#cholesterol metabolism
#t cell differentiation
|
|
0
|
|
Engineering trispecific IL-2 receptor agonistic antibodies through geometry optimization for enhanced Treg targeting.
(nature.com)
|
Lykhopiy V
…
Schlenner SM
Nature Communications
2026-07-10
|
#antibody
#immunotherapy
#autoimmunity
#immunoengineering
#tolerance
|
|
0
|
|
Another complement inhibitor therapy for myasthenia gravis: Is it NIMBLE enough?
(linkinghub.elsevier.com)
|
Kusner LL
…
Kaminski HJ
Cell Med
2026-07-10
|
#complement
#myasthenia gravis
#immunotherapy
#rnai
|
|
0
|
|
Enhancing tumor T cell antigen prediction by integrating deep protein representations.
(link.springer.com)
|
Oskay U
…
Sefer E
BMC Bioinformatics
2026-07-10
|
#cancer
#immunotherapy
#prediction
#machine learning
#proteomics
|
|
0
|
|
FDA-approved fulvestrant-induced CAR phase separation enables precise control of CAR T antitumor function.
(linkinghub.elsevier.com)
|
Huang Y
…
Wang H
Cell Stem Cell
2026-07-10
|
#car-t
#cancer
#immunotherapy
#phase separation
#protein design
|
|
0
|
|
Split immunomodulatory impact of leptin on human myeloid cells: key role of IDO1 in counteracting the immunostimulatory effect of leptin.
(academic.oup.com)
|
Dong B
…
Kalinski P
Journal of Immunology
2026-07-10
|
#cancer
#immunotherapy
#macrophage
#obesity
#ido1
|
|
0
|
|
Oncogenic EGFR rewires STING-TBK1 signalosomes to license DNA damage tolerance in NSCLC.
(link.springer.com)
|
Shen Q
…
Xu P
The EMBO Journal
2026-07-10
|
#nsclc
#chemoresistance
#signaling
#dna repair
#immunotherapy
|
|
0
|
|
Anti-LAG-3 with or without anti-PD-1 in recurrent glioblastoma: a phase 1 trial.
(nature.com)
|
Lim M
…
Grossman SA
Nature Medicine
2026-07-10
|
#immunotherapy
#glioblastoma
#t cell
#checkpoint
#oncology
|
|
0
|
|
Colorectal cancer landscape from gut microbiota: Insights into mutations, epigenetic dysregulation, and immune microenvironment alterations.
(tandfonline.com)
|
Li Y
…
Wen J
Virulence
2026-07-10
|
#microbiome
#colorectal cancer
#dysbiosis
#epigenetics
#immunotherapy
|
|
0
|
|
Long-term survivors of melanoma after anti-PD-1 therapy demonstrate on-treatment increase in abundance of 4-1BB+ CD4 T cells in blood.
(academic.oup.com)
|
de Joode K
…
Debets R
Journal of Immunology
2026-07-10
|
#immunotherapy
#melanoma
#t-cells
#biomarker
#flow cytometry
|
|
0
|
|
T-cell miR-155 regulates the response to tumor-specific mRNA vaccines in a murine model of acute myeloid leukemia.
(academic.oup.com)
|
Battistone B
…
O'Connell RM
Journal of Immunology
2026-07-10
|
#immunotherapy
#microrna
#leukemia
#vaccination
#transcriptomics
|
|
0
|
|
A novel Vdelta1 engager targeting CD19 enhances human Vdelta1 gammadelta T cell responses against CLL and CD19+ hematological malignancies.
(academic.oup.com)
|
Bhumbra SA
…
Hutton AJ
Journal of Immunology
2026-07-10
|
#immunotherapy
#leukemia
#cytotoxicity
#bispecific
#lymphocyte
|
|
0
|
|
HBsAg seroreversion after pegylated interferon alpha induced HBsAg seroclearance in patients with chronic hepatitis B: a real-world cohort study.
(link.springer.com)
|
Zhang W
…
Song J
BMC Infectious Diseases
2026-07-10
|
#hepatitis
#immunotherapy
#seroreversion
#antiviral
#prognosis
|
|
0
|
|
Isotype-switched antibodies originating from tertiary lymphoid structures can antagonize ovarian cancer progression.
(linkinghub.elsevier.com)
|
Mandal G
…
Conejo-Garcia JR
iScience
2026-07-10
|
#immunotherapy
#ovarian cancer
#immunity
#antibody
#lymphoid-structures
|
|
0
|
|
Fluorescence tracking CD8 T cells from tumor-draining lymph nodes to irradiated tumors and their activation in the tumor environment.
(academic.oup.com)
|
Friedman D
…
Gough MJ
Journal of Immunology
2026-07-10
|
#cancer
#immunotherapy
#radiotherapy
#immunity
#lymphocyte
|
|
0
|
|
CD8+ T-cell effector programming is epigenetically regulated by DUSP2 through BAF complex-driven chromatin remodeling.
(academic.oup.com)
|
Dellacecca ER
…
Dong H
Journal of Immunology
2026-07-10
|
#immunity
#epigenetics
#chromatin
#immunotherapy
#transcription
|